Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.
Column: Why the Genesis 340B Patient Definition Court Decision Could Resolve the Contract Pharmacy Impasse
Views
In what legal experts describe as a landmark decision, the U.S. District Court for the District of South Carolina ruled [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.